Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines

被引：8
|
作者：
Dizdar, Omer [1 ]
Dede, Didem S. [1 ]
Bulut, Nilufer [1 ]
Altundag, Kadri [1 ]
机构：
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, TR-06100 Ankara, Turkey
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2008年 / 107卷 / 02期
关键词：
Public Health; Breast Cancer; Cancer Cell; Estrogen; Estrogen Receptor;
D O I：
10.1007/s10549-007-9551-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：303 / 303
页数：1
相关论文
共 50 条
  • [41] Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines
    Sebastien Taurin
    Rhonda J. Rosengren
    Medical Oncology, 40
  • [42] Phenotypic, structural, and ultrastructural analysis of triple-negative breast cancer cell lines and breast cancer stem cell subpopulation
    Moreira, Milene Pereira
    Brayner, Fabio Andre
    Alves, Luiz Carlos
    Cassali, Geovanni Dantas
    Silva, Luciana Maria
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2019, 48 (07): : 673 - 684
  • [43] Phenotypic, structural, and ultrastructural analysis of triple-negative breast cancer cell lines and breast cancer stem cell subpopulation
    Milene Pereira Moreira
    Fábio André Brayner
    Luiz Carlos Alves
    Geovanni Dantas Cassali
    Luciana Maria Silva
    European Biophysics Journal, 2019, 48 : 673 - 684
  • [44] Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines
    Ku, Ja-Lok
    Park, Sung-Chan
    Kim, Kyung-Hee
    Jeon, You-Kyung
    Kim, Sung-Hee
    Shin, Young-Kyoung
    Noh, Dong-Young
    Im, Seock-Ah
    Bang, Yung-Jue
    Han, Wonshik
    Kim, Woo Ho
    Park, Jae-Gahb
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (06) : 2073 - 2081
  • [45] Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer
    Bahman, Fatemah
    Pittala, Valeria
    Haider, Mohamed
    Greish, Khaled
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [46] CHARACTERIZATION OF A C-KIT NEGATIVE PRIMITIVE MURINE HEMATOPOIETIC STEM-CELL
    KELLER, JR
    ORTIZ, M
    SPENCE, SE
    LOHREY, N
    RUSCETTI, FW
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 813 - 813
  • [47] Analyzing the effect of annonacin on diverse breast cancer cell lines as a potential therapeutic agent for triple negative breast cancer
    Hernandez-Torres, Jennifer
    Guzman, Kelly Argueta
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [48] USP2 promotes cell migration and invasion in triple negative breast cancer cell lines
    Qu, Qing
    Mao, Yan
    Xiao, Gang
    Fei, Xiaochun
    Wang, Jinglong
    Zhang, Yuzi
    Liu, Junjun
    Cheng, Guangcun
    Chen, Xiaosong
    Wang, Jianhua
    Shen, Kunwei
    TUMOR BIOLOGY, 2015, 36 (07) : 5415 - 5423
  • [49] Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer
    Cecilia L. Speyer
    Miriam A. Bukhsh
    Waris S. Jafry
    Rachael E. Sexton
    Sudeshna Bandyopadhyay
    David H. Gorski
    Breast Cancer Research and Treatment, 2017, 166 : 407 - 419
  • [50] Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines
    Pierce, Aisling
    McGowan, Patricia M.
    Cotter, Maura
    Mullooly, Maeve
    O'Donovan, Norma
    Rani, Sweta
    O'Driscoll, Lorraine
    Crown, John
    Duffy, Michael J.
    CANCER BIOLOGY & THERAPY, 2013, 14 (06) : 537 - 545
12345